Institution profile

一般財団法人 健康医学協会 粒子線がん相談クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2509004 +4

Location

Prefecture
Tokyo
Address
千代田区紀尾井町4番1号 ホテルニューオータニガーデンタワー1階

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 瀬田クリニックグループ認定再生医療等委員会
  • 一般社団法人細胞免疫学研究会認定再生医療等委員会

Public score

34.2/ 100

A · Review level
10.0 / 30
B · Technologies
20.6 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1425of 1736

Registered technologies
5
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 34.2
Public score →100

Registered technologies (5)

NK and immune cells 5
Registered technologies · Japanese originalTechnology areasPlan classification
悪性腫瘍に対するアルファ・ベータT細胞療法(血管内投与)NK and immune cellsClass III
悪性腫瘍に対するガンマ・デルタT細胞療法(血管内投与)NK and immune cellsClass III
悪性腫瘍に対するNK細胞療法(血管内投与)NK and immune cellsClass III
悪性腫瘍に対する添加法を用いた樹状細胞ワクチン療法NK and immune cellsClass III
がんに対するNK-S細胞を用いた免疫機能改善治療NK and immune cellsClass III

Certified committee for regenerative medicine

  • 瀬田クリニックグループ認定再生医療等委員会
  • 一般社団法人細胞免疫学研究会認定再生医療等委員会

Public document number

  • 02C2509004
  • 02C2509016
  • 02C2509019
  • 02C2509020
  • 02C2601040
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性腫瘍に対するアルファ・ベータT細胞療法(血管内投与)Class III瀬田クリニックグループ認定再生医療等委員会02C2509004
悪性腫瘍に対するガンマ・デルタT細胞療法(血管内投与)Class III瀬田クリニックグループ認定再生医療等委員会02C2509016
悪性腫瘍に対するNK細胞療法(血管内投与)Class III瀬田クリニックグループ認定再生医療等委員会02C2509019
悪性腫瘍に対する添加法を用いた樹状細胞ワクチン療法Class III瀬田クリニックグループ認定再生医療等委員会02C2509020
がんに対するNK-S細胞を用いた免疫機能改善治療Class III一般社団法人細胞免疫学研究会認定再生医療等委員会02C2601040

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor